Last Updated : July 24, 2025
Details
| Call for patient/clinician input open | 29-May-25 |
|---|---|
| Call for patient/clinician input closed | 18-Jul-25 |
| Submission received | 10-Jul-25 |
| Submission accepted | 24-Jul-25 |
| Review initiated | 25-Jul-25 |
| Draft CADTH review report(s) provided to sponsor for comment | 10-Oct-25 |
| Deadline for sponsors comments | 22-Oct-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 14-Nov-25 |
| Expert committee meeting (initial) | 26-Nov-25 |
| Draft recommendation issued to sponsor | December 08, 2025 To December 10, 2025 |
| Draft recommendation posted for stakeholder feedback | 18-Dec-25 |
| End of feedback period | 09-Jan-26 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 26-Nov-25 |
Details
| Call for patient/clinician input open | 29-May-25 |
|---|---|
| Call for patient/clinician input closed | 18-Jul-25 |
| Submission received | 09-Jul-25 |
| Submission accepted | 23-Jul-25 |
| Review initiated | 24-Jul-25 |
| Draft CADTH review report(s) provided to sponsor for comment | 09-Oct-25 |
| Deadline for sponsors comments | 21-Oct-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 14-Nov-25 |
| Expert committee meeting (initial) | 26-Nov-25 |
| Draft recommendation issued to sponsor | December 08, 2025 To December 10, 2025 |
| Draft recommendation posted for stakeholder feedback | 18-Dec-25 |
| End of feedback period | - |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 26-Nov-25 |
Last Updated : July 24, 2025
Details
| Call for patient/clinician input open | May 29, 2025 |
|---|---|
| Call for patient/clinician input closed | July 18, 2025 |
| Submission received | July 10, 2025 |
| Submission accepted | July 24, 2025 |
| Review initiated | July 25, 2025 |
| Draft CADTH review report(s) provided to sponsor for comment | October 10, 2025 |
| Deadline for sponsors comments | October 22, 2025 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | November 21, 2025 |
| Expert committee meeting (initial) | December 03, 2025 |
| Draft recommendation issued to sponsor | December 15, 2025 To December 17, 2025 |
| Draft recommendation posted for stakeholder feedback | January 02, 2026 |
| End of feedback period | - |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | December 03, 2025 |
Last Updated : July 25, 2025
Details
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Scoping Posted : | 29-May-25 |
| Input Deadline : | 25-Jul-25 |
This proposed scope has been updated to include PC0417 and the deadline for feedback has been extended to July 25.
Last Updated : June 4, 2025
Details
Program Updates
1. Further Streamlining the Tailored Review Process
Since the launch of the Pharmaceuticals With Anticipated Comparable Efficacy and Safety (PACES) process in February 2025, we continue to examine opportunities to further simplify the application and review process.
Last Updated : May 29, 2025
Details
Last Updated : May 26, 2025
Details
| Call for patient/clinician input open | 23-May-25 |
|---|---|
| Call for patient/clinician input closed | 18-Jul-25 |
| Submission received | 09-Jul-25 |
| Submission accepted | 23-Jul-25 |
| Review initiated | 24-Jul-25 |
| Draft CADTH review report(s) provided to sponsor for comment | 09-Oct-25 |
| Deadline for sponsors comments | 21-Oct-25 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 14-Nov-25 |
| Expert committee meeting (initial) | 26-Nov-25 |
| Draft recommendation issued to sponsor | December 08, 2025 To December 10, 2025 |
| Draft recommendation posted for stakeholder feedback | 18-Dec-25 |
| End of feedback period | 09-Jan-26 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 26-Nov-25 |
Last Updated : July 24, 2025